Emyria eyes US market with launch of high-dose CBD capsule by Steve Jones April 24, 2023April 24, 2023 Emyria has manufactured a high-potency synthetic CBD capsule with plans to register the drug in the […]
Company news: Health House; Little Green Pharma; Incannex; Emyria by Steve Jones and Martin Lane April 19, 2023April 19, 2023
Emyria strikes commercial deal with Aspen for over-the-counter product by Steve Jones April 4, 2023April 17, 2023
Company news: Neurotech; Emyria; InhaleRx by Martin Lane and Steve Jones March 23, 2023April 17, 2023
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023March 1, 2023
Company news: Delta 9 Cannabis; Little Green Pharma; Zelira Therapeutics; Emyria by Martin Lane and Steve Jones February 16, 2023February 16, 2023
Emyria and LGP shares soar after TGA approves limited access to MDMA and psilocybin by Steve Jones February 6, 2023February 7, 2023
Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023
Company news: LGP; Cann Global; Medcan; Incannex; Medlab; Emyria; RestoreMe; Releaf Group; Levin Health by Martin Lane and Steve Jones November 30, 2022December 1, 2022